KIF18B and hepatocellular carcinoma: With the qRT-PCR and IHC detection of clinical tissue samples, Yang et al. illustrated that KIF18B was significantly upregulated in hepatocellular carcinoma, thus promoting the progression of hepatocellular carcinoma by activating the Wnt/β-catenin pathway